WO2002054075A1 - Elemental analysis of tagged biologically active materials - Google Patents
Elemental analysis of tagged biologically active materials Download PDFInfo
- Publication number
- WO2002054075A1 WO2002054075A1 PCT/CA2001/001815 CA0101815W WO02054075A1 WO 2002054075 A1 WO2002054075 A1 WO 2002054075A1 CA 0101815 W CA0101815 W CA 0101815W WO 02054075 A1 WO02054075 A1 WO 02054075A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- biologically active
- active material
- sample
- analyte
- tagged
- Prior art date
Links
- 239000011149 active material Substances 0.000 title claims abstract description 152
- 238000000921 elemental analysis Methods 0.000 title description 8
- 238000000034 method Methods 0.000 claims abstract description 148
- 238000001514 detection method Methods 0.000 claims abstract description 98
- 239000000427 antigen Substances 0.000 claims abstract description 37
- 102000036639 antigens Human genes 0.000 claims abstract description 37
- 108091007433 antigens Proteins 0.000 claims abstract description 37
- 239000005556 hormone Substances 0.000 claims abstract description 5
- 229940088597 hormone Drugs 0.000 claims abstract description 5
- 239000003102 growth factor Substances 0.000 claims abstract description 3
- 239000012491 analyte Substances 0.000 claims description 93
- 238000005259 measurement Methods 0.000 claims description 61
- 108090000623 proteins and genes Proteins 0.000 claims description 57
- 102000004169 proteins and genes Human genes 0.000 claims description 57
- 241000894007 species Species 0.000 claims description 57
- 150000002500 ions Chemical class 0.000 claims description 51
- 230000003287 optical effect Effects 0.000 claims description 40
- 230000007704 transition Effects 0.000 claims description 30
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 19
- 239000010931 gold Substances 0.000 claims description 18
- 238000000608 laser ablation Methods 0.000 claims description 16
- 238000009616 inductively coupled plasma Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 229910052737 gold Inorganic materials 0.000 claims description 13
- 230000027455 binding Effects 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 8
- 229910052747 lanthanoid Inorganic materials 0.000 claims description 8
- 102000039446 nucleic acids Human genes 0.000 claims description 8
- 108020004707 nucleic acids Proteins 0.000 claims description 8
- 150000007523 nucleic acids Chemical class 0.000 claims description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 8
- 229920002401 polyacrylamide Polymers 0.000 claims description 8
- 230000008878 coupling Effects 0.000 claims description 7
- 238000010168 coupling process Methods 0.000 claims description 7
- 238000005859 coupling reaction Methods 0.000 claims description 7
- 150000002602 lanthanoids Chemical class 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 6
- 238000004113 cell culture Methods 0.000 claims description 6
- 239000010439 graphite Substances 0.000 claims description 6
- 229910002804 graphite Inorganic materials 0.000 claims description 6
- 229910000510 noble metal Inorganic materials 0.000 claims description 6
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 6
- 108020003175 receptors Proteins 0.000 claims description 6
- 102000005962 receptors Human genes 0.000 claims description 6
- 229910052709 silver Inorganic materials 0.000 claims description 6
- 239000004332 silver Substances 0.000 claims description 6
- 230000000155 isotopic effect Effects 0.000 claims description 5
- 239000011543 agarose gel Substances 0.000 claims description 4
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 claims description 4
- 229910052763 palladium Inorganic materials 0.000 claims description 4
- 229910052697 platinum Inorganic materials 0.000 claims description 4
- 229910052741 iridium Inorganic materials 0.000 claims description 3
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- 239000010948 rhodium Substances 0.000 claims description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 abstract description 32
- 239000002184 metal Substances 0.000 abstract description 31
- 150000002739 metals Chemical class 0.000 abstract description 10
- 238000004611 spectroscopical analysis Methods 0.000 abstract description 6
- 239000012620 biological material Substances 0.000 abstract description 3
- 230000009870 specific binding Effects 0.000 abstract description 3
- 238000000159 protein binding assay Methods 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 106
- 235000018102 proteins Nutrition 0.000 description 44
- 210000004027 cell Anatomy 0.000 description 35
- 239000000872 buffer Substances 0.000 description 34
- 238000003018 immunoassay Methods 0.000 description 32
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 238000004458 analytical method Methods 0.000 description 24
- 239000000243 solution Substances 0.000 description 19
- 230000000903 blocking effect Effects 0.000 description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 17
- 239000002253 acid Substances 0.000 description 13
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 12
- 238000003556 assay Methods 0.000 description 11
- -1 lanthanide metals Chemical class 0.000 description 10
- 238000004949 mass spectrometry Methods 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- 239000002738 chelating agent Substances 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
- 108060003951 Immunoglobulin Proteins 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 102000018358 immunoglobulin Human genes 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- 229910052742 iron Inorganic materials 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 229920002684 Sepharose Polymers 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 229910021645 metal ion Inorganic materials 0.000 description 6
- 229910052759 nickel Inorganic materials 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 102000057208 Smad2 Human genes 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 210000004748 cultured cell Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 229940072221 immunoglobulins Drugs 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 150000003573 thiols Chemical class 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000000020 Nitrocellulose Substances 0.000 description 4
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 229910052786 argon Inorganic materials 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 229920001220 nitrocellulos Polymers 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101710173438 Late L2 mu core protein Proteins 0.000 description 3
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 101710188315 Protein X Proteins 0.000 description 3
- 238000001636 atomic emission spectroscopy Methods 0.000 description 3
- 238000000889 atomisation Methods 0.000 description 3
- 238000013375 chromatographic separation Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 108010042653 IgA receptor Proteins 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 2
- 101800004937 Protein C Proteins 0.000 description 2
- 102000017975 Protein C Human genes 0.000 description 2
- 101710188053 Protein D Proteins 0.000 description 2
- 101710132893 Resolvase Proteins 0.000 description 2
- 101800001700 Saposin-D Proteins 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 108700032504 Smad2 Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000001593 atomic mass spectrometry Methods 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000536 complexating effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000007876 drug discovery Methods 0.000 description 2
- 238000000456 dynamic reaction cell inductively coupled plasma mass spectrometry Methods 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 229940127121 immunoconjugate Drugs 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229960000856 protein c Drugs 0.000 description 2
- 230000004850 protein–protein interaction Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000012146 running buffer Substances 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- ABXYOVCSAGTJAC-JGWLITMVSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanethial Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=S ABXYOVCSAGTJAC-JGWLITMVSA-N 0.000 description 1
- GDSOQCSYONDNAJ-UHFFFAOYSA-N 2-thiophen-2-ylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1=CC=CS1 GDSOQCSYONDNAJ-UHFFFAOYSA-N 0.000 description 1
- 102400000068 Angiostatin Human genes 0.000 description 1
- 108010079709 Angiostatins Proteins 0.000 description 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- 108091012583 BCL2 Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 101100125027 Dictyostelium discoideum mhsp70 gene Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 101150031823 HSP70 gene Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- XDSSPSLGNGIIHP-VKHMYHEASA-N Se-methyl-L-selenocysteine Chemical compound C[Se]C[C@H]([NH3+])C([O-])=O XDSSPSLGNGIIHP-VKHMYHEASA-N 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000013394 Troponin I Human genes 0.000 description 1
- 108010065729 Troponin I Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 150000001356 alkyl thiols Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 150000001504 aryl thiols Chemical class 0.000 description 1
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
- 238000000559 atomic spectroscopy Methods 0.000 description 1
- 102000055102 bcl-2-Associated X Human genes 0.000 description 1
- 108700000707 bcl-2-Associated X Proteins 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 101150052825 dnaK gene Proteins 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940111120 gold preparations Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000036046 immunoreaction Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000009149 molecular binding Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 238000001426 native polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 239000002901 radioactive waste Substances 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 239000012495 reaction gas Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229940082569 selenite Drugs 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000036964 tight binding Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010891 toxic waste Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005758 transcription activity Effects 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
- G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002554722A JP4002832B2 (en) | 2000-12-28 | 2001-12-18 | Elemental analysis of tagged biologically active substances |
CA2431864A CA2431864C (en) | 2000-12-28 | 2001-12-18 | Elemental analysis of tagged biologically active materials |
AU2002215784A AU2002215784B2 (en) | 2000-12-28 | 2001-12-18 | Elemental analysis of tagged biologically active materials |
DE60137078T DE60137078D1 (en) | 2000-12-28 | 2001-12-18 | ELEMENTARY ANALYSIS OF MARKED BIOLOGICAL ACTIVE SUBSTANCES |
EP01272578A EP1348127B1 (en) | 2000-12-28 | 2001-12-18 | Elemental analysis of tagged biologically active materials |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/258,387 | 2000-12-28 | ||
US09/905,907 US7135296B2 (en) | 2000-12-28 | 2001-07-17 | Elemental analysis of tagged biologically active materials |
US09/905,907 | 2001-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002054075A1 true WO2002054075A1 (en) | 2002-07-11 |
Family
ID=25421671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2001/001815 WO2002054075A1 (en) | 2000-12-28 | 2001-12-18 | Elemental analysis of tagged biologically active materials |
Country Status (2)
Country | Link |
---|---|
US (1) | US7135296B2 (en) |
WO (1) | WO2002054075A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005003767A2 (en) * | 2003-07-03 | 2005-01-13 | Mds Inc., Doing Business As Mds Sciex | Elemental analysis of tagged biologically active materials |
JP2006003347A (en) * | 2004-05-17 | 2006-01-05 | Ajinomoto Co Inc | Highly sensitive detection method for organic compound, and device used therefor |
US7135296B2 (en) | 2000-12-28 | 2006-11-14 | Mds Inc. | Elemental analysis of tagged biologically active materials |
JP2007530924A (en) * | 2004-03-25 | 2007-11-01 | エムディーエス インコーポレイテッド ドゥーイング ビジネス スルー イッツ エムディーエス サイエックス ディヴィジョン | Flow cytometry method and apparatus linked to elemental analysis |
WO2007137418A1 (en) | 2006-05-27 | 2007-12-06 | Winnik Mitchell A | Polymer backbone element tags |
US8101368B2 (en) | 2006-02-13 | 2012-01-24 | Dvs Sciences Inc. | Quantitation of cellular DNA and cell numbers using element labeling |
US8338126B2 (en) | 2006-02-13 | 2012-12-25 | Olga Ornatsky | Kit for detecting and measuring element tagged kinases and phosphatases by inductively coupled plasma mass spectrometry |
US8426804B2 (en) | 2010-02-26 | 2013-04-23 | Perkinelmer Health Sciences, Inc. | Multimode cells and methods of using them |
US8680464B2 (en) | 2010-04-19 | 2014-03-25 | Hitachi High-Technologies Corporation | Mass spectrometer |
US8884217B2 (en) | 2010-02-26 | 2014-11-11 | Perkinelmer Health Sciences, Inc. | Multimode cells and methods of using them |
CN104198552A (en) * | 2014-09-25 | 2014-12-10 | 江西农业大学 | Preparation method of electrochemical sensor for rapidly detecting synthetic hormone diethylstilbestrol |
US8963076B2 (en) | 2011-10-26 | 2015-02-24 | Fluidigm Canada Inc. | Sample transferring apparatus for mass cytometry |
US9465036B2 (en) | 2006-11-02 | 2016-10-11 | Fluidigm Canada Inc. | Particles containing detectable elemental code |
US9916971B2 (en) | 2010-02-26 | 2018-03-13 | Perkinelmer Health Sciences, Inc. | Systems and methods of suppressing unwanted ions |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1343973B2 (en) | 2000-11-16 | 2020-09-16 | California Institute Of Technology | Apparatus and methods for conducting assays and high throughput screening |
EP1554576B9 (en) * | 2001-12-03 | 2008-08-20 | Amgen Fremont Inc. | Identification of high affinity molecules by limited dilution screening |
US7771951B2 (en) * | 2001-12-03 | 2010-08-10 | Amgen Fremont Inc. | Antibody categorization based on binding characteristics |
JP2005512043A (en) * | 2001-12-03 | 2005-04-28 | アブジェニックス・インコーポレーテッド | Discovery of therapeutic products |
US7897378B2 (en) * | 2004-03-18 | 2011-03-01 | Roche Molecular Systems, Inc. | Method and device for purifying nucleic acids |
WO2007093050A1 (en) * | 2006-02-13 | 2007-08-23 | Olga Ornatsky | Gene expression assays conducted by elemental analysis |
CA2649154A1 (en) * | 2006-04-14 | 2007-10-25 | Proteome Factory Ag | Method and reagent for the specific identification and quantification of one or more proteins in a sample using inductively coupled plasma-mass spectrometry |
WO2008019492A1 (en) | 2006-08-15 | 2008-02-21 | Alexei Antonov | Apparatus and method for elemental analysis of particles by mass spectrometry |
US8026108B1 (en) * | 2006-10-19 | 2011-09-27 | The University Of Central Florida Research Foundation, Inc. | Detection of biotargets using bioreceptor functionalized nanoparticles |
US7880140B2 (en) * | 2007-05-02 | 2011-02-01 | Dh Technologies Development Pte. Ltd | Multipole mass filter having improved mass resolution |
CZ2009350A3 (en) * | 2009-05-29 | 2010-12-08 | Sellier & Bellot A. S. | Marking of after shot products |
US20190300945A1 (en) * | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
WO2012097070A1 (en) | 2011-01-11 | 2012-07-19 | The Board Of Trustees Of The Leland Stanford Junior University | Mass dots: nanoparticle isotope tags |
GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
US9261503B2 (en) | 2012-10-26 | 2016-02-16 | Fluidigm Canada Inc. | Cell analysis by mass cytometry |
CN102998267B (en) * | 2012-11-23 | 2015-03-25 | 四川中自尾气净化有限公司 | Spectrophotometric detection method for contents of platinum and rhodium |
AU2013382989B2 (en) | 2013-03-22 | 2018-06-07 | Eth Zurich | Laser ablation cell |
US9218949B2 (en) | 2013-06-04 | 2015-12-22 | Fluidigm Canada, Inc. | Strategic dynamic range control for time-of-flight mass spectrometry |
CN111662960B (en) | 2013-06-25 | 2024-04-12 | 普罗格诺西斯生物科学公司 | Spatially encoded bioanalytical analysis using microfluidic devices |
CN104655610B (en) * | 2015-01-28 | 2018-05-01 | 攀钢集团研究院有限公司 | The analysis method and assay method of vanadyl oxalate oxalate ion concentration |
DK3901281T3 (en) | 2015-04-10 | 2023-01-23 | Spatial Transcriptomics Ab | SPATIALLY SEPARATE, MULTIPLEX NUCLEIC ACID ANALYSIS OF BIOLOGICAL SAMPLES |
WO2016182402A1 (en) * | 2015-05-13 | 2016-11-17 | (주)에스엘에스 | Simultaneous analysis method for multiple targets using multiple metal nano-tags |
WO2016207916A1 (en) * | 2015-06-26 | 2016-12-29 | Maggenome Technologies Pvt. Ltd. | Entrapment of magnetic nanoparticles in a cross-linked protein matrix without affecting the functional properties of the protein |
EP3426774A4 (en) | 2016-03-10 | 2019-08-14 | The Board of Trustees of the Leland Stanford Junior University | Transposase-mediated imaging of the accessible genome |
CN106353392A (en) * | 2016-08-26 | 2017-01-25 | 内蒙古包钢钢联股份有限公司 | Method for determining scandium content in steel |
CN107037113A (en) * | 2016-11-24 | 2017-08-11 | 北京毅新博创生物科技有限公司 | A kind of ICPMS detection kits for being used to detect 20 kinds of elements in serum |
CN106525552A (en) * | 2016-11-28 | 2017-03-22 | 天津大学 | Serum sample diluent and detection kit |
CN108254364A (en) * | 2016-12-28 | 2018-07-06 | 苏州电器科学研究院股份有限公司 | The detection method of gold dollar cellulose content in a kind of electronic material |
CN110320201A (en) * | 2018-03-30 | 2019-10-11 | 上海梅山钢铁股份有限公司 | The detection method of cobalt content in a kind of monel |
US11307206B2 (en) | 2018-04-27 | 2022-04-19 | Deutsches Rheuma-Forschungszentrum Berlin | Functionalized metal-labeled beads for mass cytometry |
US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
WO2020123320A2 (en) | 2018-12-10 | 2020-06-18 | 10X Genomics, Inc. | Imaging system hardware |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
WO2020243579A1 (en) | 2019-05-30 | 2020-12-03 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
EP4025711A2 (en) | 2019-11-08 | 2022-07-13 | 10X Genomics, Inc. | Enhancing specificity of analyte binding |
CN110715974A (en) * | 2019-11-20 | 2020-01-21 | 武汉上谱分析科技有限责任公司 | Method for determining rare earth elements in ultrabasic rock by utilizing ICP-MS (inductively coupled plasma-mass spectrometry) |
ES2946357T3 (en) | 2019-12-23 | 2023-07-17 | 10X Genomics Inc | Methods for spatial analysis using RNA template ligation |
US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
EP4242325A3 (en) | 2020-04-22 | 2023-10-04 | 10X Genomics, Inc. | Methods for spatial analysis using targeted rna depletion |
WO2021236929A1 (en) | 2020-05-22 | 2021-11-25 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
WO2021237087A1 (en) | 2020-05-22 | 2021-11-25 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
WO2021242834A1 (en) | 2020-05-26 | 2021-12-02 | 10X Genomics, Inc. | Method for resetting an array |
WO2021252499A1 (en) | 2020-06-08 | 2021-12-16 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
EP4165207A1 (en) | 2020-06-10 | 2023-04-19 | 10X Genomics, Inc. | Methods for determining a location of an analyte in a biological sample |
WO2021263111A1 (en) | 2020-06-25 | 2021-12-30 | 10X Genomics, Inc. | Spatial analysis of dna methylation |
US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
EP4121555A1 (en) | 2020-12-21 | 2023-01-25 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
WO2023034489A1 (en) | 2021-09-01 | 2023-03-09 | 10X Genomics, Inc. | Methods, compositions, and kits for blocking a capture probe on a spatial array |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4022876A (en) * | 1973-06-21 | 1977-05-10 | Stanford Research Institute | Mass spectrometric immunoassay |
US4205952A (en) * | 1976-05-31 | 1980-06-03 | Technion Research & Development Foundation Ltd. | Specific binding assay method and reagent means |
US4454233A (en) * | 1981-10-21 | 1984-06-12 | Wang Associates | Method of tagged immunoassay |
US5907034A (en) * | 1990-03-07 | 1999-05-25 | Behring Diagnostics Gmbh | Monoclonal antibody against complexed and non-complexed complexing agents for removing heavy metals from aqueous solutions and for analysis |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7807532A (en) * | 1978-07-13 | 1980-01-15 | Akzo Nv | METAL IMMUNO TEST. |
US4411993A (en) | 1981-04-29 | 1983-10-25 | Steven Gillis | Hybridoma antibody which inhibits interleukin 2 activity |
US4637988A (en) | 1981-07-01 | 1987-01-20 | Eastman Kodak Company | Fluorescent labels for immunoassay |
US4543439A (en) | 1982-12-13 | 1985-09-24 | Massachusetts Institute Of Technology | Production and use of monoclonal antibodies to phosphotyrosine-containing proteins |
US4902614A (en) | 1984-12-03 | 1990-02-20 | Teijin Limited | Monoclonal antibody to human protein C |
US5071775A (en) * | 1986-08-13 | 1991-12-10 | Massachusetts Institute Of Technology | Indirect labeling method for post-separation detection of chemical compounds |
NZ291154A (en) | 1994-07-25 | 1997-11-24 | Boehringer Mannheim Gmbh | Di- or trivalent rare earth or transition metal complexes having three ligands, each of which has at least two nitrogen-containing heterocycles and complexed through nitrogen, and at least one reactive group bound to the ligard(s) |
US5521289A (en) * | 1994-07-29 | 1996-05-28 | Nanoprobes, Inc. | Small organometallic probes |
AU7245596A (en) | 1995-09-25 | 1997-04-17 | Robert Eric Montgomery | Tooth bleaching compositions |
US6140638A (en) | 1997-06-04 | 2000-10-31 | Mds Inc. | Bandpass reactive collision cell |
US6428956B1 (en) * | 1998-03-02 | 2002-08-06 | Isis Pharmaceuticals, Inc. | Mass spectrometric methods for biomolecular screening |
US6222186B1 (en) * | 1998-06-25 | 2001-04-24 | Agilent Technologies, Inc. | Power-modulated inductively coupled plasma spectrometry |
JP2002536295A (en) | 1998-12-14 | 2002-10-29 | パラチン テクノロジーズ, インク. | Metallic peptide combination library and its use |
JP2002208127A (en) | 2000-11-09 | 2002-07-26 | Fuji Electric Co Ltd | Magnetic recording medium and manufacturing method therefor |
US7135296B2 (en) | 2000-12-28 | 2006-11-14 | Mds Inc. | Elemental analysis of tagged biologically active materials |
US6746679B2 (en) | 2001-08-02 | 2004-06-08 | Oral Health Clinical Services Llc | Tooth whitening hydrogels |
US6770266B2 (en) | 2002-05-24 | 2004-08-03 | Colgate Palmolive Company | Liquid tooth whitening composition |
-
2001
- 2001-07-17 US US09/905,907 patent/US7135296B2/en not_active Expired - Lifetime
- 2001-12-18 WO PCT/CA2001/001815 patent/WO2002054075A1/en active Search and Examination
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4022876A (en) * | 1973-06-21 | 1977-05-10 | Stanford Research Institute | Mass spectrometric immunoassay |
US4205952A (en) * | 1976-05-31 | 1980-06-03 | Technion Research & Development Foundation Ltd. | Specific binding assay method and reagent means |
US4454233A (en) * | 1981-10-21 | 1984-06-12 | Wang Associates | Method of tagged immunoassay |
US5907034A (en) * | 1990-03-07 | 1999-05-25 | Behring Diagnostics Gmbh | Monoclonal antibody against complexed and non-complexed complexing agents for removing heavy metals from aqueous solutions and for analysis |
Non-Patent Citations (6)
Title |
---|
BARANOV, V.I. ET AL: "A sensitive and quantitative element-tagged immunoassay with ICPMS detection", ANALYTICAL CHEMISTRY, vol. 74, no. 7, 1 April 2002 (2002-04-01), pages 1629 - 1636, XP001068480 * |
BLAKE, D A ET AL: "Immunoassays for metal ions", ANALYTICA CHIMICA ACTA, vol. 376, 1998, pages 13 - 19, XP001063361 * |
DARWISH I A ET AL: "ONE-STEP COMPETITIVE IMMUNOASSAY FOR CADMIUM IONS: DEVELOPMENT AND VALIDATION FOR ENVIRONMENTAL WATER SAMPLES", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 73, no. 8, 15 April 2001 (2001-04-15), pages 1889 - 1895, XP001030286, ISSN: 0003-2700 * |
EVANS R DOUGLAS ET AL: "A method for characterization of humic and fulvic acids by gel electrophoresis laser ablation inductively coupled plasma mass spectrometry.", JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY., vol. 15, no. 2, February 2000 (2000-02-01), pages 157 - 161, XP001068410, ISSN: 0267-9477 * |
NEILSEN J L ET AL: "Laser ablation inductively coupled plasma-mass spectrometry in combination with gel electrophoresis: A new strategy for speciation of metal binding serum proteins.", SPECTROCHIMICA ACTA PART B ATOMIC SPECTROSCOPY, vol. 53, no. 2, February 1998 (1998-02-01), pages 339 - 345, XP001068501, ISSN: 0584-8547 * |
ZHANG CHAO ET AL: "A novel combination of immunoreaction and ICP-MS as a hyphenated technique for the determination of thyroid-stimulating hormone (TSH) in human serum.", JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY, vol. 16, no. 12, December 2001 (2001-12-01), December, 2001, pages 1393 - 1396, XP001068414, ISSN: 0267-9477 * |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700295B2 (en) | 2000-12-28 | 2010-04-20 | Mds Sciex | Elemental analysis of tagged biologically active materials |
US7135296B2 (en) | 2000-12-28 | 2006-11-14 | Mds Inc. | Elemental analysis of tagged biologically active materials |
US7767407B2 (en) | 2000-12-28 | 2010-08-03 | Perkinelmer Health Sciences, Inc. | Elemental analysis of tagged biologically active materials |
WO2005003767A3 (en) * | 2003-07-03 | 2005-06-30 | Mds Inc Dba Mds Sciex | Elemental analysis of tagged biologically active materials |
WO2005003767A2 (en) * | 2003-07-03 | 2005-01-13 | Mds Inc., Doing Business As Mds Sciex | Elemental analysis of tagged biologically active materials |
US8525107B2 (en) | 2004-03-25 | 2013-09-03 | Perkinelmer Health Sciences, Inc. | Magnetic sector mass spectrometry based multi-parametric particle analyzer |
US10436698B2 (en) | 2004-03-25 | 2019-10-08 | Fluidigm Corporation | Mass spectrometry based multi-parametric particle analyzer |
JP2007530924A (en) * | 2004-03-25 | 2007-11-01 | エムディーエス インコーポレイテッド ドゥーイング ビジネス スルー イッツ エムディーエス サイエックス ディヴィジョン | Flow cytometry method and apparatus linked to elemental analysis |
US10180386B2 (en) | 2004-03-25 | 2019-01-15 | Fluidigm Corporation | Mass spectrometry based multi-parametric particle analyzer |
US9952134B2 (en) | 2004-03-25 | 2018-04-24 | Fluidigm Corporation | Mass spectrometry based multi-parametric particle analyzer |
JP2006003347A (en) * | 2004-05-17 | 2006-01-05 | Ajinomoto Co Inc | Highly sensitive detection method for organic compound, and device used therefor |
US8101368B2 (en) | 2006-02-13 | 2012-01-24 | Dvs Sciences Inc. | Quantitation of cellular DNA and cell numbers using element labeling |
US8338126B2 (en) | 2006-02-13 | 2012-12-25 | Olga Ornatsky | Kit for detecting and measuring element tagged kinases and phosphatases by inductively coupled plasma mass spectrometry |
US9874567B2 (en) | 2006-02-13 | 2018-01-23 | Fluidigm Canada Inc. | Kits to assay kinase activity |
US8790886B2 (en) | 2006-02-13 | 2014-07-29 | Fluidigm Canada Inc. | Methods to assay kinase activity |
US9284598B2 (en) | 2006-02-13 | 2016-03-15 | Fluidigm Canada Inc. | Methods to assay phosphatase activity |
US9284597B2 (en) | 2006-02-13 | 2016-03-15 | Fluidigm Canada Inc. | Methods to assay kinase activity |
US9012239B2 (en) | 2006-05-27 | 2015-04-21 | Fluidigm Canada Inc. | Polymer backbone element tags |
EP2444804A2 (en) | 2006-05-27 | 2012-04-25 | Mitchell A. Winnik | Polymer backbone element tags |
EP2960263A1 (en) | 2006-05-27 | 2015-12-30 | Fluidigm Canada Inc. | Polymer backbone element tags |
US20200362062A1 (en) * | 2006-05-27 | 2020-11-19 | Fluidigm Canada Inc. | Polymer backbone element tags |
US10752707B2 (en) | 2006-05-27 | 2020-08-25 | Fluidigm Canada Inc. | Polymer backbone element tags |
US9296838B2 (en) | 2006-05-27 | 2016-03-29 | Fluidigm Canada, Inc. | Polymer backbone element tags |
US10669358B2 (en) | 2006-05-27 | 2020-06-02 | Fluidigm Canada Inc. | Polymer backbone element tags |
WO2007137418A1 (en) | 2006-05-27 | 2007-12-06 | Winnik Mitchell A | Polymer backbone element tags |
EP3260863A1 (en) | 2006-05-27 | 2017-12-27 | Fluidigm Canada Inc. | Method for performing multiplex analysis of two or more analytes |
US10072104B2 (en) | 2006-05-27 | 2018-09-11 | Fluidigm Canada Inc. | Polymer backbone element tags |
US9465036B2 (en) | 2006-11-02 | 2016-10-11 | Fluidigm Canada Inc. | Particles containing detectable elemental code |
US10871436B2 (en) | 2006-11-02 | 2020-12-22 | Fluidigm Canada Inc. | Particles containing detectable elemental code |
US9916971B2 (en) | 2010-02-26 | 2018-03-13 | Perkinelmer Health Sciences, Inc. | Systems and methods of suppressing unwanted ions |
US8426804B2 (en) | 2010-02-26 | 2013-04-23 | Perkinelmer Health Sciences, Inc. | Multimode cells and methods of using them |
US8884217B2 (en) | 2010-02-26 | 2014-11-11 | Perkinelmer Health Sciences, Inc. | Multimode cells and methods of using them |
US8680464B2 (en) | 2010-04-19 | 2014-03-25 | Hitachi High-Technologies Corporation | Mass spectrometer |
US8963076B2 (en) | 2011-10-26 | 2015-02-24 | Fluidigm Canada Inc. | Sample transferring apparatus for mass cytometry |
US9431227B2 (en) | 2011-10-26 | 2016-08-30 | Fluidigm Canada Inc. | Sample transferring apparatus for mass cytometry |
CN104198552A (en) * | 2014-09-25 | 2014-12-10 | 江西农业大学 | Preparation method of electrochemical sensor for rapidly detecting synthetic hormone diethylstilbestrol |
Also Published As
Publication number | Publication date |
---|---|
US7135296B2 (en) | 2006-11-14 |
US20020086441A1 (en) | 2002-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7135296B2 (en) | Elemental analysis of tagged biologically active materials | |
US7767407B2 (en) | Elemental analysis of tagged biologically active materials | |
Chahrour et al. | Stable isotope labelling methods in mass spectrometry-based quantitative proteomics | |
US9470692B2 (en) | Mass spectrometric analysis | |
Liu et al. | Inductively coupled plasma mass spectrometry‐based immunoassay: A review | |
JP5468391B2 (en) | Mass spectrometry quantitative method | |
Che et al. | Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags | |
WO2014186874A1 (en) | Methods and compositions for enzyme linked immuno and hybridization mass spectrometric assay | |
EP2467350B1 (en) | Mass labels | |
Mounicou et al. | Inductively-coupled plasma mass spectrometry in proteomics, metabolomics and metallomics studies | |
EP1348127B1 (en) | Elemental analysis of tagged biologically active materials | |
AU2002215784A1 (en) | Elemental analysis of tagged biologically active materials | |
AU2002256060B2 (en) | Methods and kits useful for the simplification of complex peptide mixtures | |
Tian et al. | Selective maleylation-directed isobaric peptide termini labeling for accurate proteome quantification | |
Kim et al. | Quantitative analysis of low-abundance serological proteins with peptide affinity-based enrichment and pseudo-multiple reaction monitoring by hybrid quadrupole time-of-flight mass spectrometry | |
AU2002256060A1 (en) | Methods and kits useful for the simplification of complex peptide mixtures | |
Deng et al. | Reaction cell inductively coupled plasma mass spectrometry-based immunoassay using ferrocene tethered hydroxysuccinimide ester as label for the determination of 2, 4-dichlorophenoxyacetic acid | |
Ion et al. | Immuno-affinity mass spectrometry: a novel approaches with biomedical relevance | |
JP6482577B2 (en) | Analysis method and analysis apparatus | |
CN113588769A (en) | Preparation method of porous alloy nano material and application of porous alloy nano material in detection of plasma metabolites | |
JP2004513345A (en) | Continuous flow homogeneous biochemical analysis method based on detection of known ligands by mass spectrometry | |
Dunlap | Investigation of the Analytical Utility of the Inductively Coupled Plasma Mass Spectrometer (ICP-MS) for the Quantification of Proteins via Lanthanide Labeling | |
Engin | Development of chromatographic and electrochemical methods for trastuzumab determination | |
Powers et al. | Applications of nuclear magnetic resonance and mass spectrometry to anticancer drug discovery | |
Brancia et al. | Development of novel guanidino‐labelling derivatisation (GLaD) reagents for liquid chromatography/matrix‐assisted laser desorption/ionisation analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001272578 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002215784 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2431864 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002554722 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001272578 Country of ref document: EP |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |